Bone metastases in patients with small cell lung carcinoma: Rate of development, modality of treatment, and their impact on survival.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e18559-e18559
Author(s):  
Konstantinos N. Syrigos ◽  
Dimitrios Vassos ◽  
Ioannis Gkiozos ◽  
Paraskevi Boura ◽  
Serafeim Kaltsas ◽  
...  
Keyword(s):  
Bone Metastases ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Rate Of Development ◽  
Impact On Survival

Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinoma

Lung Cancer ◽  
1993 ◽  
Vol 8 (5-6) ◽  
pp. 301-308 ◽  
Author(s):  
F. de Vathaire ◽  
R. Arriagada ◽  
H. de Thé ◽  
M. Tarayre ◽  
P. Ruffie ◽  
...  
Keyword(s):  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Dose Intensity ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Impact On Survival

Reevaluation of the Usefulness of Systematic Bone Scanning in Initial Staging and follow-up of Small Cell Lung Carcinoma, Taking into Account the Serum Levels of Neuron-Specific Enolase

1997 ◽  
Vol 12 (4) ◽  
pp. 148-153 ◽  
Author(s):  
V. Gendreau ◽  
F. Montravers ◽  
C. Philippe ◽  
J.N. Talbot
Keyword(s):  
Bone Metastases ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
False Negative ◽  
Neuron Specific Enolase ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma ◽  
Initial Staging

The prescription of bone scans (BS) in the initial staging and follow-up of small cell lung carcinoma (SCLC) is a traditional attitude. The availability of the serum neuron-specific enolase (NSE) assay and budget limitations led us to evaluate retrospectively, in 57 patients, the consequences of a more selective attitude, namely to perform BS only in those patients with abnormal serum NSE levels. Both BS and NSE assays were performed in 47 patients referred for initial staging of SCLC; NSE levels were normal in 8 but in 2 of these cases (25%) secondary bone localizations with great clinical significance were discovered at BS. During follow-up, 59 BS were performed in conjunction with NSE assays; 45 NSE levels were in the normal range whereas 17 (38%) corresponding BS were suggestive of bone metastases. In conclusion, due to the frequent occurrence of false-negative results in patients with bone metastases, serum NSE levels proved to be useless in the selection for BS of patients suffering from SCLC.

Bone Marrow Necrosis: An Unusual Presenting Feature of Small Cell Lung Carcinoma

1985 ◽  
Vol 71 (4) ◽  
pp. 403-406 ◽  
Author(s):  
Patrizia Paterlini ◽  
Lanfranco Venturoni ◽  
Girolamo Cretara ◽  
Manlio Ricciotti ◽  
Dennis Quaglino
Keyword(s):  
Bone Marrow ◽  
Bone Metastases ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Clinical Feature ◽  
Small Cell Lung ◽  
Bone Marrow Necrosis ◽  
Cell Lung Carcinoma

The authors describe a case of bone-marrow necrosis which represented the initial clinical feature of a « small cell » lung carcinoma with bone metastases.

Clinical Features And Outcomes Of Patients With Small Cell Lung Carcinoma; Retrospective Analysis

2015 ◽  
Vol 3 (2) ◽  
pp. 47 ◽  
Author(s):  
Duygu Unalmış ◽  
Zehra Yasar ◽  
Melih Buyuksirin ◽  
Gulru Polat ◽  
Fatma Demirci Ucsular ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Clinical Features ◽  
Lung Carcinoma ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document